All Posts By

greg goldstein


Global Hip Reconstruction Device Market on the Rise

By | DePuy Hip Implants, Orthopedic Implants, Stryker Hip Implants, Wright Conserve Hip Implant | No Comments

In 2014, the global hip reconstruction devices market was valued at $4.8 billion. By 2020, it is anticipated to rise to $5.9 billion. Hip implant devices, manufactured and distributed by companies such as Stryker, Zimmer, DePuy, Smith & Nephew, Biomet and Wright, are popular options to replace damaged and deteriorated joints caused by aging, disease, osteoarthritis or injury. Read More


Stryker Orthopedics to Acquire Sage Products

By | Stryker Hip Implants | No Comments

Furthering its recent expansion plans, Stryker Orthopedics, manufacturer of the recalled Rejuvenate and ABG II modular hip implant systems subject to multidistrict litigation in Minnesota federal court (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441), has reached an agreement to acquire Sage Products for $2.775 billion in cash — its largest ever acquisition. Read More

Orthopedic Implant Sales Expected to Double

By | DePuy Hip Implants, Orthopedic Implants, Stryker Hip Implants, Wright Conserve Hip Implant | No Comments

Global sales for hip and knee implants in 2015 were approximately $17 billion. In 2015, 324,000 people underwent hip replacement surgery in the United States alone. By 2022, the hip and knee implant market is projected to grow to $33 billion, resulting from a growing aging population across the globe. Read More

Natural Alternatives to Testosterone Replacement Therapy

By | Testosterone Replacement Therapy | No Comments

Traditional testosterone replacement therapy has included the use of drugs and implants which are now the subject of thousands of lawsuits across the United States including the pending multidistrict litigation (MDL) in Illinois federal court to resolve common issues among the cases (In re: Testosterone Replacement Therapy Products Liability Litigation, MDL No. 2545). However, many commonly recommended natural alternatives to combat low testosterone (“Low T”) have been identified. Read More

Testosterone Replacement Therapy (TRT) and Prostate Cancer

By | Testosterone Replacement Therapy | No Comments

Testosterone replacement therapy may be required for prostate cancer patients who have undergone androgen deprivation therapy (ADT) to treat prostate cancer. ADT blocks the production or effects of androgens, such as testosterone and dihydrotestosterone (DHT), which are the male sex hormones that promote male characteristics such as facial hair, sexual function and muscle mass. Read More